Summary of findings table ‐ Emicizumab prophylaxis vs on‐demand therapy
QoL · people with inhibitors
1 finding from 1 review
- Non‐clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 40 participantsLow